We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$559M
AUM Growth
-$6.54M
Cap. Flow
-$4.83M
Cap. Flow %
-0.87%
Top 10 Hldgs %
65.7%
Holding
77
New
3
Increased
6
Reduced
4
Closed
2
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
FGNA.U
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
+$5M
2
ADVM icon
Adverum Biotechnologies
ADVM
+$2.25M
3
TGTX icon
TG Therapeutics
TGTX
+$1.61M
4
MRNS icon
Marinus Pharmaceuticals, Inc
MRNS
+$1.02M
5
FATE icon
Fate Therapeutics
FATE
+$697K

Top Sells

Rank Stock Value
1
ARKO icon
ARKO Corp
ARKO
+$10.3M
2
BLFS icon
BioLife Solutions
BLFS
+$3.46M
3
FLNA icon
Filana Therapeutics
FLNA
+$1.65M
4
DRRX icon
DURECT Corp
DRRX
+$501K
5
CUE icon
Cue Biopharma
CUE
+$288K

Sector Composition

Rank Sector Weight
1 Healthcare 26.25%
2 Industrials 17.34%
3 Miscellaneous 16.1%
4 Energy 10.35%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ARKO icon
76
ARKO Corp
ARKO
$461M
– –
-1,000,000
Closed -$10.3M –
BLFS icon
77
DELISTED
BioLife Solutions
BLFS
– –
-211,942
Closed -$3.46M –
1 2 3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q3 2020 Portfolio in Review

As of Q3 2020, Bleichroeder LP held 77 positions worth $559M, down 1.2% from $565M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP's Q3 2020 filing shows 3 new, 6 increased, 4 reduced and 2 closed positions. Its largest new stake was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M. The largest sale was ARKO Corp, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 29% a quarter earlier, followed by Industrials and Miscellaneous.

  • Bleichroeder LP's largest Q3 2020 buy was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M.
  • Bleichroeder LP added most to Marinus Pharmaceuticals, Inc in Q3 2020, an estimated $1.02M increase.
  • Bleichroeder LP's biggest Q3 2020 reduction was Filana Therapeutics, cutting an estimated $1.65M.
  • Bleichroeder LP fully exited ARKO Corp in Q3 2020, selling an estimated $10.3M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $559M portfolio in Q3 2020.
  • Bleichroeder LP opened 3 new positions and closed 2 in Q3 2020.
  • Bleichroeder LP's portfolio value fell 1.2% quarter-over-quarter to $559M.

Based on Bleichroeder LP's 13F filing for Q3 2020, filed 12 Nov 2020.